Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation

Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation is the treatment of choice for many hematologic diseases, such as multiple myeloma, bone marrow aplasia and leukemia. Human leukocyte antigen (HLA) compatibility is an important tool to prevent post-transplant complications such as graft rejection and graft-ve...

Full description

Bibliographic Details
Main Authors:	Danilo Santana Alessio Franceschi, Cármino Antonio de Souza, Francisco José Penteado Aranha, Daniela Maira Cardozo, Ana Maria Sell, Jeane Eliete Laguila Visentainer
Format:	Article
Language:	English
Published:	Elsevier 2011-01-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Hematopoietic stem cell Histocompatibility testing Receptor KIR HLA antigens Killer cells, natural Graft vs host disease
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200011

Similar Items

Association of paternal HLA-C and maternal killer-cell immunoglobulin-like receptor genotypes in the development of autism
by: Moriya Gamliel, et al.
Published: (2016-07-01)

Ligand specificity of Killer cell Immunoglobulin-like Receptors: a brief history of KIR
by: Jeroen eVan Bergen, et al.
Published: (2012-12-01)

Role of KIR typing in donor selection prior to allogeneic hematopoietic stem cell transplantation: literature review
by: V. V. Zakharova
Published: (2019-01-01)

Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population
by: Marlon Castrillon, et al.
Published: (2022-09-01)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
by: Antonino Tuttolomondo, et al.
Published: (2019-04-01)

Genes of killer cell immunoglobulin-like receptors and their HLA ligands after allogeneic hematopoietic stem cell transplantation in myeloid leukemia patients
by: E G Khamaganova, et al.
Published: (2015-11-01)

Otimização de metodologia para o estudo de genes KIR Methodology optimization for KIR genotyping
by: Cristiane Conceição Chagas Rudnick, et al.
Published: (2010-06-01)

Células natural killer e vigilância imunológica Natural killer cells and immune surveillance
by: Mariana Jobim, et al.
Published: (2008-08-01)

Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
by: Heleen Neeltje Haspels, et al.
Published: (2018-06-01)

Genetic features of the killer cell immunoglobulin-like receptors in the haematopoietic stem cell donors
by: Iu. V. Sokolova, et al.
Published: (2014-07-01)

Genetic features of the killer cell immunoglobulin-like receptors in the haematopoietic stem cell donors
by: Iu. V. Sokolova, et al.
Published: (2014-07-01)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
by: Amy K. Erbe, et al.
Published: (2017-06-01)

Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation
by: Yanmin Zhao, et al.
Published: (2021-02-01)

Distribution of Killer-Cell Immunoglobulin-Like Receptor Genes and Combinations of Their Human Leucocyte Antigen Ligands in 11 Ethnic Populations in China
by: Yufeng Yao, et al.
Published: (2019-07-01)

Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer
by: Roberto Diaz-Peña, et al.
Published: (2020-02-01)

Dynamic Changes of Inhibitory Killer-Immunoglobulin-Like Receptors on NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation: An Initial Study
by: Tereza Dekojová, et al.
Published: (2020-10-01)

Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor
by: Carolyn E. Behrendt, et al.
Published: (2013-02-01)

Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil
by: Janaina Mota de Vasconcelos, et al.
Published: (2013-01-01)

Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia
by: Dhon Roméo Makanga, et al.
Published: (2020-07-01)

HLA and non-HLA polymorphisms in renal transplantation
by: Stéphanie Laperrousaz, et al.
Published: (2012-08-01)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
by: Simona Carlomagno, et al.
Published: (2017-05-01)

Natural Killer Cell Education Is Associated With a Distinct Glycolytic Profile
by: Caroline Pfeifer, et al.
Published: (2018-12-01)

Killer instincts: natural killer cells as multifactorial cancer immunotherapy
by: Sarah Nersesian, et al.
Published: (2023-11-01)

Associations of Genes for Killer Cell Immunoglobulin-like Receptors and Their Human Leukocyte Antigen-A/B/C Ligands with Abdominal Aortic Aneurysm
by: Joanna Dubis, et al.
Published: (2021-11-01)

Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
by: Lixia Sheng, et al.
Published: (2020-07-01)

High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han
by: Sudan Tao, et al.
Published: (2021-04-01)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
by: John P. Veluchamy, et al.
Published: (2017-05-01)

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma
by: Giorgio La Nasa, et al.
Published: (2016-03-01)

Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
by: Yu Zhang, et al.
Published: (2023-01-01)

KIR And HLA Haplotype Analysis in a Family Lacking The KIR 2DL1-2DP1 Genes
by: Vojvodić Svetlana, et al.
Published: (2015-06-01)

Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoietic stem cell transplantation
by: Adèle Dhuyser, et al.
Published: (2023-03-01)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
by: Kyle B. Lupo, et al.
Published: (2019-06-01)

Decoding the diversity of killer immunoglobulin-like receptors by deep sequencing and a high-resolution imputation method
by: Saori Sakaue, et al.
Published: (2022-03-01)

Killer cell immunoglobulin receptor diversity and its relevance in the human host’s response to HIV infection in African populations
by: John Mukisa, et al.
Published: (2023-03-01)

The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor haematopoietic stem cell transplantation for myeloid malignancies
by: Hua Wang, et al.
Published: (2012-12-01)

Stable Frequencies of HLA-C*03:04/Peptide-Binding KIR2DL2/3+ Natural Killer Cells Following Vaccination
by: Maja Christiane Ziegler, et al.
Published: (2018-10-01)

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
by: Daniela Pende, et al.
Published: (2019-05-01)

Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology
by: Bercelin Maniangou, et al.
Published: (2017-05-01)

Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor
by: Federica Cattina, et al.
Published: (2017-09-01)

“HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex”
by: Erick Velastegui, et al.
Published: (2023-07-01)